References
- NORDCAN–IARC https://www.kreftregisteret.no or https://www–dep.iarc.fr/nordcan/fi/frame.asp.
- Statistics on cancer in Nordic countries. 2022. https://nordcan.iarc.fr/.
- Wong MCS, Huang J, Chan PSF, et al. Global incidence and mortality of gastric cancer, 1980–2018. JAMA Netw Open. 2021;4(7):e2118457.
- Lin Y, Zheng Y, Wang H–L, et al. Global patterns and trends in gastric incidence rates (1988–2012) and predictions to 2030. Gastroenterology. 2021;161(1):116–127.e8.
- Sipponen P. Prevalence rates of heathy stomach mucosa, chronic non–atrophic and atrophic gastritis in endoscopic biopsies in adults born in Finland in 1890–1977. Scand J Gastroenterol. 2021;56(8):874–881.
- Sipponen P, Sarna S, Vohlonen I. When will Helicobacter pylori gastritis disappear in history in Finland? Scand J Gastroenterol. 2022;57(2):154–157.
- Helicobacter pylori IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241. PMCID: PMC7681621
- Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19(Suppl 1):S37–S43.
- Sipponen P. Helicobacter pylori: a cohort phenomenon. Am J Surg Pathol. 1995;19(Suppl 1):S30–S6.
- Wold S, Sjöström M, Eriksson L. PLS–regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems. 2001;58(2):109–130.
- Wold S, Ruhe H, Wold H, et al. The collinearity problem in linear regression. The partial squares approach to generalized inverses. SIAM J Sci and Stat Comput. 1984;5(3):735–743.
- Eriksson L, Antti H, Gottfries J, et al. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem. 2004;380(3):419–429. .
- Tu Y–K, Smith CG, Gilthorpe MS. A new approach to age–period–cohort analysis using partial least squares regression: the trend in blood pressure in the glasgow alumni cohort. PLoS One. 2011;6(4):e19401.
- Pukkala E, Engholm G, Højsgaard Schmidt LK, et al. Nordic cancer registries–an overview of their procedures and data comparability. Acta Oncol. 2018;57(4):440–455.
- Leinonen MK, Miettinen J, Heikkinen S, et al. Quality measures of the population–based finnish cancer registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–39.
- Lumivero 2023. XLSTAT statistical and data analysis solution. New York, USA. https://www.xlstat.com/en.
- Sipponen P, Helske T, Järvinen P, et al. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut. 1994;35(9):1167–1171.
- Rehnberg–Laiho L, Rautelin H, Koskela P, et al. Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect. 2001;126(1):37–42.
- Sonnenberg A. Epidemiology of Helicobacter pylori. Aliment Pharmacol Ther. 2022;55 Suppl 1(Suppl 1):S1–S13.
- Roosendaal R, Kuipers EJ, Buitenwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol. 1997;92(9):1480–1482.
- Hooi JKY, Lai W, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta–analysis. Gastrtoenterology. 2017;53:420–429.
- Sipponen P, Kekki M, Siurala M. The Sydney system: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol. 1991;6(3):244–251.
- Sipponen P, Maaroos H–I. Chronic gastritis. Scand J Gastroenterol. 2015;50(6):657–667.
- Correa P. Chronic gastritis: a clinico–pathological classification. Am J Gastroenterol. 1988;83(5):504–509.
- Ihamäki T, Kekki M, Sipponen P, et al. The sequelae and course of chronic gastritis during a 30–to 34–year bioptic follow–up study. Scand J Gastroenterol. 1985;20(4):485–491.
- Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161–1181.
- Kuipers EJ, Uyterlinde AM, Peña AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995;345(8964):1525–1528.
- Villako K, Maards H, Tammur R, et al. Helicobacter (Campylobacter) pylori infestation and the development and progression of chronic gastritis: results of long–term follow–up examinations of a random sample. Endoscopy. 1990;22(3):114–117.
- Correa P. The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res. 1980;6:98–108.
- Sipponen P, Kekki M, Haapakoski J, et al. Gastric cancer risk in chronic atrophic gastritis. Statistical calculations of cross-sectional data. Int J Cancer. 1985;35(2):173–177.
- Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31:1104–1111.
- Sipponen P, Kosunen TU, Valle J, et al. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol. 1992;45(4):319–323.
- Komoto K, Haruma K, Kamada T, et al. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol. 1998;93(8):1271–1276.
- Yusefi AR, Lankarani KB, Bastani P, et al. Risk factors for gastric cancer: a systematic review. Asian Pac J Cancer Prev. 2018;19:591–603.
- Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
- Moayyedi P, Axon ATR, Feltbower R, et al. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol. 2002;31(3):624–631.
- Chapelle N, Manfredi S, Lepage C, et al. Trends in gastric cancer incidence: a period and birth cohort analysis in a well–defined French population. Gastric Cancer. 2016;19(2):682–682.
- Sonnenberg A. Differences in the birth-cohort patterns of gastric cancer and peptic ulcer. Gut. 2010;59(6):736–743.
- Wang C, Weber A, Graham DY. Age, period, and cohort effects on gastric cancer mortality. Dig Dis Sci. 2015;60(2):514–523.
- Lin Y, Lin S, Chen J, et al. Time trends and age-period-cohort effects on the incidence of gastric cancer in Changle from 2003 to 2012. Cancer Manag Res. 2019;11:8885–8892.
- Kuzmickiene I, Everatt R. Trends and age-period-cohort analysis of upper aerodigestive tract and stomach cancer mortality in Lithuania, 1987–2016. Public Health. 2021;196:62–68.
- Luo G, Zhang Y, Guo P, et al. Global patterns and trends in stomach cancer incidence: age, period and birth cohort analysis. Int J Cancer. 2017;141(7):1333–1344.
- Decarli A, La Vecchia C, Mezzanotte G, et al. Birth cohort, time, and age effects in Italian cancer mortality. Cancer. 1987;59(6):1221–1232.
- Aragonés N, Pollán M, Rodero I, et al. Gastric cancer in the European union (1968–1992): mortality trends and cohort effect. Ann Epidemiol. 1997;7(4):294–303.
- Okui T. An age-period-cohort analysis of mortality rates for stomach, colorectal, liver, and lung cancer among prefectures in Japan, 1999-2018. Environ Health Prev Med. 2020;25(1):80.
- Seoane–Mato D, Aragonés N, Ferreras E, et al. Trends in oral cavity, pharyngeal, oesophageal, and gastric cancer mortality rates in Spain, 1952–2006: an age–period–cohort analysis. BMC Cancer. 2014;254(14):1–11.